Addiction & Substances

Prescription Drug Addiction: Signs, Risks and Help

By Craig Bilton, Founder & Clinical Director · Updated 28 August 2026 · 23 min read

Scope: This guide provides general education. It cannot diagnose dependence or addiction, identify an unknown tablet, change a prescription or provide an individual withdrawal schedule. Insight Recovery Network is not a regulated healthcare provider and does not prescribe or provide emergency care. Speak to the prescriber, a GP, pharmacist or specialist drug and alcohol service before changing a medicine.

The concise answer

Prescription drug addiction is a pattern in which there is a strong drive to take a prescribed or pharmacy medicine, difficulty controlling its use and continued use despite harm. It is not the same as physical dependence. A person can develop tolerance, dependence and withdrawal while taking a medicine exactly as directed, without craving, intoxication-seeking or compulsive behaviour. Other people experience both dependence and addiction.[1][2]

The medicines most often linked with these concerns include opioid painkillers, benzodiazepines, Z-drugs and gabapentinoids. Prescription stimulants can also be misused. Antidepressants may cause withdrawal, but are not considered addictive in the same way.[1][8]

The safe response is an accurate, non-judgemental review of every medicine and substance, the condition being treated, overdose and withdrawal risk, and the person's goals. Do not stop or reduce a dependence-forming medicine because of an online article. NICE advises that these medicines should not usually be stopped abruptly; any reduction should be individualised, agreed and reviewed with the responsible clinician.[1]

> Get urgent help now: Call 999 or go to A&E if someone cannot be woken, has stopped breathing or is breathing very slowly, has blue or grey lips or skin, has a seizure, has collapsed, is severely confused, or may have taken a harmful amount. Call NHS 111 if more than the prescribed amount may have been taken and there is no immediate life-threatening sign, or if you are unsure whether a medicine exposure is harmful.[7][9]

Table of contents

1. Key takeaways
2. What prescription drug addiction means
3. Dependence, addiction, tolerance and withdrawal
4. Medicines that can cause dependence or addiction
5. Signs prescription medicine use may be becoming harmful
6. Why the problem can be hard to recognise
7. Main risks and dangerous combinations
8. Withdrawal and why medicine class matters
9. What a safe assessment should cover
10. Treatment and recovery in the UK
11. Community, online, residential or inpatient care
12. Practical steps to take today
13. Harm reduction while waiting for care
14. How families and friends can help
15. When professional support is needed
16. Frequently asked questions

Key takeaways

• Prescribed status does not remove the possibility of dependence, addiction, side effects, interactions or overdose.
• Physical dependence is not proof of addiction. Addiction includes impaired control, strong desire and continued use despite harm.
• Opioids, benzodiazepines, Z-drugs, gabapentinoids and prescription stimulants have different effects and withdrawal risks. One generic “prescription drug detox” plan is not safe.
• Antidepressant withdrawal is real, but antidepressants are not generally considered addictive in the same way as opioids or benzodiazepines. They still should not be stopped suddenly without advice.[8]
• Mixing opioids with benzodiazepines, gabapentinoids, Z-drugs, alcohol or other sedatives can increase drowsiness and breathing risk.[2][3][6]
• Assessment should cover the exact product and use, all sources, other substances, previous withdrawal, overdose, health, safety and the condition being treated.
• Treatment may combine prescribing review, individual withdrawal planning, specialist addiction care, psychological support and management of the underlying problem.
• Never use an online dose-reduction schedule as personal medical advice. Withdrawal may take months or longer for some people and must be adjusted to symptoms, risk and circumstances.[1]

What is prescription drug addiction?

The term prescription drug addiction is commonly used when a medicine has become difficult to control and use continues despite physical, psychological, relationship, work or safety consequences. It may have been prescribed, bought from a pharmacy, shared or sourced online; the clinical pattern matters more than where it came from.

Addiction is not defined by taking any controlled medicine, using it for a long time or experiencing withdrawal. Possible features include craving, repeated unsuccessful efforts to cut down, using more often or for different reasons than agreed, spending increasing time obtaining or recovering from the medicine, and continuing despite clear harm.

The word “addiction” can feel accusatory when someone followed clinical advice and later found that stopping was difficult. NICE asks professionals to use sensitive, non-blaming language and to explain that dependence can be an expected effect of some medicines. That distinction is not semantic politeness; it changes the assessment and the plan.[1]

If the pattern extends beyond medicine use into cue-driven relief, compulsion and continued harm, the plain-language guide to how addiction works explains why good intentions alone may not be enough.

Dependence, addiction, tolerance and withdrawal are different

These terms overlap, but they should not be treated as synonyms.

Physical dependence means the body has adapted to repeated exposure. Missing a dose, reducing it or stopping may produce withdrawal symptoms. It can happen during correct prescribed use and does not by itself show compulsive behaviour.

Addiction involves a strong drive to use, impaired control and continuation despite harm. A person may take extra doses for sedation, emotional escape or stimulation; seek early prescriptions; conceal use; or keep taking the medicine after falls, overdose, conflict or worsening function.

Tolerance means that the same amount produces less of an effect or that a person feels a need for more to obtain the previous effect. The appropriate response is clinical review, not self-escalation. Reduced benefit may also reflect progression of pain, sleep or mental-health problems, a different diagnosis, an interaction or expectations that the medicine cannot meet.[1][2]

Withdrawal describes symptoms that occur when exposure falls. Withdrawal does not prove addiction. It can resemble the original condition: anxiety returns after reducing a sedative, insomnia follows a sleeping tablet reduction, or pain intensifies during opioid withdrawal. Timing, symptom pattern and clinical review help distinguish withdrawal from relapse or a new health problem.[1]

The addiction warning signs guide can help place medicine use within the wider pattern of control, priorities, concealment and consequences.

Which prescription medicines can cause dependence or addiction?

“Prescription drugs” is not one clinical category. Each medicine must be identified precisely, including whether it is standard-release, modified-release, a patch, liquid or a combination product.

Other medicines can also be misused or cause harmful withdrawal. An online list cannot determine the risks of an individual product. Keep the packaging and ask a pharmacist or prescriber to identify the medicine, its formulation and relevant interactions.

Signs that prescription medicine use may be becoming harmful

No single sign proves addiction. Concern rises when several features appear together, intensify or continue despite consequences.

Someone can have a serious problem without appearing intoxicated. They may remain employed and collect prescriptions from one practice while spending much of the day managing withdrawal between doses. Conversely, a stable person taking a dependence-forming medicine as agreed should not be labelled addicted because of the medicine name alone.

Why prescription medicine problems can be difficult to recognise

The medicine may still have a legitimate purpose. Pain, panic, insomnia, epilepsy or ADHD may be disabling. Review should assess current benefit, growing harms and other ways to support the condition.

Dependence can develop without rule-breaking. Someone who followed instructions may feel frightened or ashamed when withdrawal appears. Non-blaming, shared decisions support honest disclosure.[1]

Prescriptions can become fragmented. A hospital, GP, private specialist and online service may each hold only part of the picture. Create one complete record and clarify prescribing responsibility.

Withdrawal can look like treatment failure. Symptoms after a missed dose may be mistaken for proof that the medicine is still essential. A clinician should review whether withdrawal, the original problem or both are present.

Combination products hide additional risk. Someone focused on codeine may overlook paracetamol in the same product. A pharmacist can check duplication; brand familiarity is not a safety check.

Online or counterfeit medicines are uncertain. Packaging does not prove contents or strength. Unexpected opioids or sedatives make overdose and withdrawal less predictable, so tell clinicians every source.

Main risks of prescription drug addiction and dependence

Risk depends on the medicine, amount, formulation, health, tolerance, interactions and whether the product is genuine. The following themes require particular attention.

Sedation and breathing problems

Opioids can slow breathing. Benzodiazepines, Z-drugs, gabapentinoids, alcohol and other sedatives can add to drowsiness and respiratory depression. The fact that two medicines were both prescribed does not guarantee that the combination remains safe after dose changes, new illness, reduced tolerance or use of alcohol.[2][3][6]

Call 999 if someone is very difficult to wake, has stopped breathing, is breathing slowly or irregularly, has blue or grey lips or skin, has collapsed or has a seizure. Do not leave them to “sleep it off”. Use available naloxone for suspected opioid overdose according to the training and product instructions, but always call 999 because its effect can wear off and other substances may be involved.[10]

Falls, driving and impaired judgement

Sedation, dizziness, blurred vision, slowed reaction time and poor coordination can cause falls, road collisions and workplace injury. Older age, frailty, breathing illness and several sedating medicines can increase vulnerability. Do not drive, cycle in traffic, work at height or use machinery if the medicine affects alertness or coordination. Ask the prescriber or pharmacist if you are unsure.

Pain, sleep and mental health

Long-term opioid use can sometimes be associated with increased pain sensitivity rather than improving function.[3] Sedatives may provide short-term relief while contributing to daytime impairment or a cycle in which anxiety and insomnia feel worse between doses. Prescription stimulants taken differently from the treatment plan can disrupt sleep, mood and cardiovascular safety.

Depression, anxiety, trauma, ADHD, chronic pain and addiction can reinforce one another. The answer is neither to ignore the mental-health condition nor to assume the medicine explains everything. IRN's mental health and addiction guide describes why both sides need coordinated assessment.

Overdose after reduced tolerance

Tolerance can fall after abstinence, detoxification, hospital admission or a period of reduced use. Returning to a previous opioid amount can then cause overdose. This risk is one reason opioid treatment needs continuing support and overdose planning, not withdrawal alone. Take-home naloxone may be supplied by drug services and other authorised professionals for people at risk and those around them.[4][10]

Pregnancy, physical illness and safeguarding

Pregnancy, breastfeeding, epilepsy, respiratory disease, kidney or liver problems, older age and acute mental-health risk can change the balance of benefit, harm and withdrawal planning. A child finding a medicine, an impaired adult caring for children, or pressure to share prescriptions creates a safeguarding concern. Seek professional advice early rather than waiting for a crisis.

Withdrawal: why the medicine class matters

Withdrawal symptoms and medical risks are not interchangeable.

NICE advises against abruptly stopping an opioid, benzodiazepine, gabapentinoid, Z-drug or antidepressant except in exceptional medical circumstances. When withdrawal is appropriate, the pace should be agreed with the person, usually slow and stepwise, with smaller changes at lower doses for some medicine groups and regular opportunities to pause or adjust. Withdrawal can take several months or more and may be delayed or prolonged.[1]

That is a set of clinical principles, not a schedule. The article deliberately gives no tablet conversions, percentage reductions or substitution instructions. A plan copied from the internet cannot account for the actual formulation, co-prescribed medicines, epilepsy, pregnancy, previous seizures, counterfeit exposure or the condition being treated. The Addiction Detox in the UK guide explains why withdrawal suitability has to be assessed rather than assumed.

What a prescription medicine assessment should cover

A useful assessment is collaborative, specific and class-by-class. “I take painkillers and something for sleep” is not enough information to plan safely.

Expect questions about:

• the name, strength, formulation and original reason for every prescribed medicine
• what is actually taken on a typical day, including extra, missed or clustered doses
• the time of the last dose and what happens before the next one
• every source: GP, hospital, private prescriber, pharmacy purchase, family member, friend or online seller
• combination products and over-the-counter medicines that may duplicate an ingredient
• alcohol, opioids, benzodiazepines, gabapentinoids, Z-drugs, stimulants, cannabis and other drug use
• tolerance, craving, loss of control, early prescriptions, concealment and previous attempts to reduce
• withdrawal symptoms, seizures, severe confusion, hallucinations or previous medically supported withdrawal
• overdose, naloxone access, falls, blackouts, breathing problems and reduced tolerance
• pain, sleep, anxiety, depression, trauma, ADHD, epilepsy and other reasons the medicine is used
• physical health, pregnancy, kidney or liver function and prescribed interactions
• self-harm, suicide risk, psychosis, exploitation, childcare and other safeguarding concerns
• driving, machinery, work, finances, housing and relationship consequences
• who currently holds prescribing responsibility and whether clinicians can coordinate information
• the person's goals, worries, previous helpful support and preferred pace of change.

Take medicine packets, repeat-prescription information and a written account where possible. Do not bring loose unknown tablets into an ordinary appointment without asking the service how to handle them safely.

Biological testing may sometimes support substance-use assessment, but it cannot by itself establish addiction, current impairment or the source and strength of a tablet. The result should be a proportionate plan: immediate safety actions, prescribing responsibility, review of the treated condition, withdrawal management if appropriate, psychological or addiction support, and a clear route if symptoms worsen.

IRN's confidential detox and withdrawal assessment can help organise risk and suitability questions. It is not a prescription, diagnosis or substitute for a GP, pharmacist or specialist prescriber.

Prescription drug addiction treatment in the UK

Treatment depends on whether the main problem is expected physical dependence, medication-related harm, an addictive pattern or a combination of these.

Coordinated medication review

The first task is to establish who is clinically responsible for each medicine and to share an accurate account across services with the person's consent. A GP, specialist prescriber or pharmacist can review current benefit, side effects, interactions, duplication and whether the original condition needs a different approach.

This review should not become a punishment. NICE advises shared decision-making, non-judgemental language and enough time to explore the person's circumstances. If the person is anxious about withdrawal or previous prescribing decisions, that concern should be acknowledged rather than used as evidence of “drug seeking”.[1]

Individual withdrawal management

If reduction is appropriate, the responsible clinician agrees the sequence, pace, formulation and review arrangements. The plan may need to slow, pause or change if symptoms become difficult. When several dependence-forming medicines are involved, deciding which to address first is a clinical judgement.[1][2]

Withdrawal management is not the same as recovery treatment. A technically completed taper will not resolve uncontrolled pain, panic, trauma, insomnia, loneliness, a cue-driven relief pattern or access to unregulated medicines. Those maintaining factors need their own plan.

Specialist treatment for opioid dependence

Some people with opioid dependence benefit from specialist medication such as methadone or buprenorphine within a supervised treatment programme. NICE recommends both as options for maintenance treatment, chosen case by case with the responsible clinician and provided with supportive care.[11]

This is different from copying an opioid taper or substituting one opioid at home. Induction carries toxicity risks when tolerance, other sedatives or the actual opioid exposure is uncertain. A specialist drug service should assess and prescribe.

Psychological and recovery support

When use has become compulsive, treatment may address craving, cues, emotional regulation, relapse prevention, problem-solving, relationships and rebuilding activities that do not depend on intoxication or relief from withdrawal. Pain, anxiety, sleep or ADHD support should be integrated rather than deferred indefinitely.

Family or partner involvement can help when the person consents and it is safe. Support should also address shame: becoming dependent on a prescribed medicine does not erase personal responsibility, but shame rarely improves disclosure, adherence or safety.

The dual-diagnosis guide explains what coordinated care should look like when significant mental-health and substance-use needs coexist.

Community, online, residential or inpatient care?

The least restrictive safe setting is usually preferred, but the right setting depends on medicine class, exposure, health, support and immediate risk.

Prescriber-led community care may suit a person with a confirmed medicine supply, manageable risk, stable housing, reliable follow-up and no indication for inpatient monitoring. Community care can still be intensive and multidisciplinary.

Specialist drug and alcohol treatment is important when opioids or other medicines are being used compulsively, unregulated products are involved, overdose risk is present or prescribing and addiction care need coordination. NHS information explains that a GP can provide treatment or refer to a local service, and people can also approach many local services directly.[13]

Structured online recovery may support a medically stable adult with behavioural change, accountability and relapse planning. It cannot identify unknown tablets, prescribe, supervise a medically risky withdrawal or respond to overdose. Review the scope and limits of online recovery programmes only after clinical safety has been addressed.

Residential treatment may be considered after repeated community-treatment difficulty, when the home is unsafe or complex needs require sustained structure. Check prescribing, medical and emergency capability; accommodation alone does not show that a service can manage withdrawal.

Inpatient medical or psychiatric care may be needed after overdose, severe withdrawal, uncontrolled seizures, delirium, acute psychosis, immediate suicide risk or another serious health complication. Emergency care should not be delayed while arranging private treatment.

IRN's treatment placement service can help compare private settings after an appropriate assessment. The selected provider remains responsible for its clinical assessment, admission decision, prescribing and emergency arrangements.

Practical steps to take today

1. Do not make an abrupt change

Keep taking the medicine as prescribed unless a qualified clinician dealing with an exceptional medical circumstance tells you otherwise. Do not skip doses to “test” dependence, double a dose after missing one or replace the medicine with alcohol, street tablets or somebody else's prescription.

2. Build one accurate list

Write down every prescribed, pharmacy, online and non-prescribed product, including patches, liquids and combination painkillers. Record the label directions and the actual pattern without altering it for the sake of the list. Note which clinician or pharmacy supplied each item.

3. Separate emergency risk from the longer plan

If too much may have been taken, call 111 or 999 according to the symptoms rather than waiting for a routine appointment. If there is no immediate emergency, contact the prescriber or GP and explain that you are concerned about dependence, addiction or withdrawal.

4. Describe what the medicine is doing now

Note current benefit, side effects, what happens after a missed dose, what prompts extra use and the effect on pain, sleep, mood, memory, work and relationships. This is more useful than saying only that the medicine “works” or “doesn't work”.

5. Ask who coordinates the plan

If several services prescribe, ask who will hold overall responsibility and how information will be shared. Agree the next review date, whom to contact if symptoms become intolerable and which signs require urgent help.

6. Add support for the original problem

A medicine change is harder if severe pain, insomnia, panic, trauma symptoms or ADHD remain unsupported. Ask what non-medicine, psychological or specialist treatment can run alongside the medication plan.

Harm reduction while waiting for care

These steps can reduce some immediate risks; they do not make misuse safe or replace assessment.

• Take medicines only as currently prescribed while awaiting advice. Do not take extra because the previous amount feels less effective.
• Avoid alcohol, illicit opioids, non-prescribed sedatives and “sleep aids” unless a pharmacist or prescriber has confirmed that an over-the-counter product is compatible.
• Check combination products with a pharmacist so that codeine, paracetamol, ibuprofen or another ingredient is not duplicated.
• Keep medicines in their original labelled packaging and store them securely away from children, visitors and anyone who may take them unintentionally.
• Do not share, sell or borrow prescription medicines. Do not assume an online tablet is genuine because the packaging looks professional.
• Do not drive or use machinery if alertness, vision, coordination or judgement is affected.
• If opioids are involved, ask a local drug service or other authorised supplier about take-home naloxone and training. Naloxone is an emergency measure, not a substitute for calling 999.[10]
• Tell a trusted person about overdose warning signs and where any supplied naloxone is kept.
• Keep follow-up appointments and report intolerable withdrawal symptoms, severe mood change or new physical symptoms promptly.

How families and friends can help

Choose a calm time when the person is alert. Describe specific observations: “You have run out early twice and were difficult to wake on Sunday” is more useful than “You are a prescription drug addict”. Ask what the medicine helps with as well as what it is costing.

Do not hide, discard or suddenly take away a dependent person's medicine. That can trigger withdrawal, break trust and drive unsafe sourcing. Do not give your own tablets, manage a taper or negotiate doses on behalf of a prescriber.

You can help build the medicine list, attend an appointment with consent, collect naloxone training where appropriate and support practical changes around driving, safe storage and childcare. Call 999 for loss of consciousness, breathing difficulty, seizure, collapse or another emergency.

Families need support and boundaries in their own right. The support for families affected by addiction guide covers communication, confidentiality, safeguarding and self-care.

When professional support is needed

Arrange a prescriber, GP, pharmacist or specialist drug-service review when:

• the medicine is being taken differently from the agreed plan
• repeated attempts to reduce have failed or withdrawal drives rapid return
• prescriptions are used early or obtained from several uncoordinated sources
• tablets are borrowed, bought online or of uncertain contents
• craving, secrecy or preoccupation is increasing
• pain, sleep, mood or functioning is worsening despite continued use
• there are falls, blackouts, memory problems, impaired driving or accidental extra doses
• opioids are combined with alcohol, benzodiazepines, Z-drugs, gabapentinoids or other sedatives
• there has been an overdose or naloxone has been needed
• pregnancy, epilepsy, breathing illness, kidney or liver disease, serious mental illness or safeguarding concerns are present
• community plans have repeatedly broken down or the home environment is unsafe.

Use NHS 111 when medicine exposure may be harmful and the situation is urgent but not immediately life-threatening. Call 999 or go to A&E for stopped or severely impaired breathing, inability to wake, seizure, collapse, severe confusion, suspected poisoning or immediate danger to self or others.[9]

Asking for help does not commit someone to abrupt withdrawal or residential treatment. It creates the information needed to choose a safer, proportionate next step.

References

1. National Institute for Health and Care Excellence. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215). Published 20 April 2022; accessed 28 August 2026.
2. Medicines and Healthcare products Regulatory Agency. Improving information supplied with gabapentinoids, benzodiazepines and Z-drugs. Published 8 January 2026.
3. Medicines and Healthcare products Regulatory Agency. Opioids: risk of dependence and addiction. Published 23 September 2020.
4. Department of Health and Social Care. Drug misuse and dependence: UK guidelines on clinical management. Published 14 July 2017; page updated 13 August 2026.
5. NHS. Codeine. Last reviewed 9 June 2026.
6. NHS. Common questions about pregabalin. Last reviewed 20 January 2026.
7. NHS. Zopiclone. Accessed 28 August 2026.
8. NHS. Antidepressants; NICE. Depression in adults: treatment and management (NG222). Accessed 28 August 2026.
9. NHS. Poisoning. Last reviewed 12 June 2025.
10. Department of Health and Social Care. Supplying take-home naloxone without a prescription. Updated 12 September 2025.
11. National Institute for Health and Care Excellence. Methadone and buprenorphine for the management of opioid dependence (TA114). Published 24 January 2007.
12. NHS. Common questions about methylphenidate for adults. Accessed 28 August 2026.
13. NHS. Drug addiction: getting help. Accessed 28 August 2026.